Skin transplantation to monitor clinical donor-related tolerance in mixed hematopoietic chimerism

被引:14
作者
Mache, CJ
Schwinger, W
Spendel, S
Zach, O
Regauer, S
Ring, E
机构
[1] Med Univ Graz, Dept Pediat, A-8036 Graz, Austria
[2] Med Univ Graz, Dept Pediat Hematol Oncol, A-8036 Graz, Austria
[3] Med Univ Graz, Dept Plast Surg, A-8036 Graz, Austria
[4] Elisabethinen Hosp Linz, Dept Internal Med 1, Linz, Austria
[5] Med Univ Graz, Inst Pathol, A-8036 Graz, Austria
关键词
hematopoietic chimerism; skin transplantation; immunologic tolerance; graft acceptance;
D O I
10.1111/j.1399-3046.2005.00412.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Mixed hematopoietic chimerism usually carries with it the tolerance to any other tissue from the same donor. Consequently, the establishment of a sustained chimerism may allow long-term acceptance of transplanted organs without immunosuppression. We report a girl with refractory severe aplastic anemia who developed low recipient level hematopoietic chimerism following transplantation of maternal highly purified CD34(+) cells without prophylactic immunosuppression. Renal thrombotic microangiopathy led to chronic renal failure and she received skin allografts from her mother in view of a future kidney donation. The maternal skin grafts were accepted without immunosuppression and the hematopoietic chimerism remained stable. Skin transplantation may be a helpful and easily applicable tool to monitor donor-related tolerance in hematopoietic chimerism clinically. It should contribute to minimize the risks of subsequent solid organ transplantation from the same donor without immunosuppression.
引用
收藏
页码:128 / 131
页数:4
相关论文
共 19 条
[1]   Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction [J].
Alizadeh, M ;
Bernard, M ;
Danic, B ;
Dauriac, C ;
Birebent, B ;
Lapart, C ;
Lamy, T ;
Le Prisé, PY ;
Beauplet, A ;
Bories, D ;
Semana, G ;
Quelvennec, E .
BLOOD, 2002, 99 (12) :4618-4625
[2]   ACTIVELY ACQUIRED TOLERANCE OF FOREIGN CELLS [J].
BILLINGHAM, RE ;
BRENT, L ;
MEDAWAR, PB .
NATURE, 1953, 172 (4379) :603-606
[3]   Graft-versus-host disease following living donor liver transplantation: high risk when the donor is HLA-homozygous [J].
Calmus, Y .
JOURNAL OF HEPATOLOGY, 2004, 41 (03) :505-507
[4]   Mixed chimerism and transplantation tolerance [J].
Cosimi, AB ;
Sachs, DH .
TRANSPLANTATION, 2004, 77 (06) :943-946
[5]   Outcomes of recipients of both bone marrow and solid organ transplants - A review [J].
Dey, B ;
Sykes, M ;
Spitzer, TR .
MEDICINE, 1998, 77 (05) :355-369
[6]   Outcomes of renal transplantation following bone marrow transplantation [J].
Hamawi, K ;
de Magalhaes-Silverman, M ;
Bertolatus, JA .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (03) :301-305
[7]  
HUBER C, 1981, J IMMUNOL, V127, P726
[8]  
KAMEI Y, 1993, TRANSPLANTATION, V56, P1530
[9]   Hemolytic uremic syndrome after allogeneic or autologous hematopoietic stem cell transplantation for childhood malignancies [J].
Kondo, M ;
Kojima, S ;
Horibe, K ;
Kato, K ;
Matsuyama, T .
BONE MARROW TRANSPLANTATION, 1998, 21 (03) :281-286
[10]   Specific memory within innate immune systems [J].
Kurtz, J .
TRENDS IN IMMUNOLOGY, 2005, 26 (04) :186-192